- testing |
| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Nov 2025 | 7 Nov 2025 |
| Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited financial results for Q-2 FY26. Q2 FY26 Financial Results along with limited review report thereon Q2 FY26 Financial Results along with Limited Review Report thereon (As Per BSE Announcement Dated on:14.11.2025) | ||
| Board Meeting | 6 Aug 2025 | 1 Aug 2025 |
| Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve unaudited financial results for Q-1 FY26 Q1 FY26 Results and Others Please find attached the Q1-FY 26 Unaudited Financial Results (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 21 Jun 2025 | 21 Jun 2025 |
| Re-appointment of Mrs. (Dr.) Savita as an Independent Director for a second term of 5 years | ||
| Board Meeting | 12 May 2025 | 5 May 2025 |
| Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Financial Results Q4 & FY25 and recommend final dividend if any for the financial year ended March 31 2025 Outcome of Board meeting held on May 12, 2025 Approved the final dividend of Rs. 0.20/- per equity share of the face value of Rs. 2/- each for the financial year ended March 31, 2025, subject to approval of the members of the Company at the ensuing Annual General Meeting (As Per BSE Announcement Dated on :12.05.2025) | ||
| Board Meeting | 28 Apr 2025 | 28 Apr 2025 |
| Please find attached the file | ||
| Board Meeting | 6 Feb 2025 | 3 Feb 2025 |
| MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve unaudited financial results for the quarter ended December 31 2024. Please find attached results and LLR - Q3 FY 25 (As Per BSE Announcement dated on 06.02.2025) | ||
| Board Meeting | 14 Jan 2025 | 14 Jan 2025 |
| Please find attached outcome of Board Meeting. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.